Zalicus (ZLCS +11.1%) takes off after announcing the FDA has approved the sale of 32mg tablets...

|By:, SA News Editor

Zalicus (ZLCS +11.1%) takes off after announcing the FDA has approved the sale of 32mg tablets for Covidien's (COV +0.6%) Exalgo pain-relief drug. The sale of 8, 12, and 16mg tablets was approved in 2010. Zalicus receives royalties on Exalgo sakes. (PR)